Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomarkers of Progression after HIV Acute/Early Infection: Nothing Compares to CD4⁺ T-cell Count?
Turk G, Ghiglione Y, Hormanstorfer M, Laufer N, Coloccini R, Salido J, Trifone C, Ruiz MJ, Falivene J, Holgado MP, Caruso MP, Figueroa MI, Salomón H, Giavedoni LD, Pando MLÁ, Gherardi MM, Rabinovich RD, Pury PA, Sued O. Turk G, et al. Among authors: figueroa mi. Viruses. 2018 Jan 13;10(1):34. doi: 10.3390/v10010034. Viruses. 2018. PMID: 29342870 Free PMC article.
Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.
Socías ME, Sued O, Laufer N, Lázaro ME, Mingrone H, Pryluka D, Remondegui C, Figueroa MI, Cesar C, Gun A, Turk G, Bouzas MB, Kavasery R, Krolewiecki A, Pérez H, Salomón H, Cahn P; Grupo Argentino de Seroconversión Study Group. Socías ME, et al. Among authors: figueroa mi. J Int AIDS Soc. 2011 Aug 10;14:40. doi: 10.1186/1758-2652-14-40. J Int AIDS Soc. 2011. PMID: 21831310 Free PMC article.
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial.
Cahn P, Andrade-Villanueva J, Arribas JR, Gatell JM, Lama JR, Norton M, Patterson P, Sierra Madero J, Sued O, Figueroa MI, Rolon MJ; GARDEL Study Group. Cahn P, et al. Among authors: figueroa mi. Lancet Infect Dis. 2014 Jul;14(7):572-80. doi: 10.1016/S1473-3099(14)70736-4. Epub 2014 Apr 27. Lancet Infect Dis. 2014. PMID: 24783988 Clinical Trial.
Host genetic factors associated with symptomatic primary HIV infection and disease progression among Argentinean seroconverters.
Coloccini RS, Dilernia D, Ghiglione Y, Turk G, Laufer N, Rubio A, Socías ME, Figueroa MI, Sued O, Cahn P, Salomón H, Mangano A, Pando MÁ. Coloccini RS, et al. Among authors: figueroa mi. PLoS One. 2014 Nov 18;9(11):e113146. doi: 10.1371/journal.pone.0113146. eCollection 2014. PLoS One. 2014. PMID: 25406087 Free PMC article.
Effect of valaciclovir on CD4 count decline in untreated HIV: an international randomized controlled trial.
Tan DHS, Raboud JM, Szadkowski L, Grinsztejn B, Madruga JV, Figueroa MI, Cahn P, Barton SE, Clarke A, Fox J, Zubyk W, Walmsley SL; VALIDATE Study Group. Tan DHS, et al. Among authors: figueroa mi. J Antimicrob Chemother. 2019 Feb 1;74(2):480-488. doi: 10.1093/jac/dky433. J Antimicrob Chemother. 2019. PMID: 30376108 Free PMC article. Clinical Trial.
Phenotype, Polyfunctionality, and Antiviral Activity of in vitro Stimulated CD8+ T-Cells From HIV+ Subjects Who Initiated cART at Different Time-Points After Acute Infection.
Salido J, Ruiz MJ, Trifone C, Figueroa MI, Caruso MP, Gherardi MM, Sued O, Salomón H, Laufer N, Ghiglione Y, Turk G. Salido J, et al. Among authors: figueroa mi. Front Immunol. 2018 Oct 23;9:2443. doi: 10.3389/fimmu.2018.02443. eCollection 2018. Front Immunol. 2018. PMID: 30405632 Free PMC article.
38 results